Vericel (VCEL) Share-based Compensation (2010 - 2026)

Vericel's (VCEL) quarterly Share-based Compensation came in at $11.3 million in Q1 2026, down 1.83% year-on-year from $11.5 million in Q1 2025, and up 34.09% quarter-over-quarter from $8.4 million in Q4 2025.

Vericel (VCEL) Share-based Compensation (2010 - 2026) Analysis & Trends

Vericel has disclosed Share-based Compensation across 17 years of filings, most recently posting $11.3 million for Q1 2026.

  • Share-based Compensation for Q1 2026 came in at $11.3 million, down 1.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $38.6 million (up 1.02% YoY), and the FY2025 annual result was $38.8 million, up 6.23% from the prior year.
  • Share-based Compensation came in at $11.3 million for Q1 2026 at Vericel, up from $8.4 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $11.5 million in Q1 2025 to a low of $6.9 million in Q4 2023.
  • The 5-year median for Share-based Compensation is $9.1 million (2022), against an average of $9.2 million.
  • Across the five-year window, Share-based Compensation surged 35.79% in 2022 and retreated 18.94% in 2023, its largest moves.
  • Vericel's Share-based Compensation stood at $7.7 million in 2022, then fell by 10.74% to $6.9 million in 2023, then advanced by 14.59% to $7.9 million in 2024, then climbed by 6.39% to $8.4 million in 2025, then surged by 34.09% to $11.3 million in 2026.
  • The last three Share-based Compensation figures came in at $11.3 million (Q1 2026), $8.4 million (Q4 2025), and $8.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 305,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 166.40 Mn
9 Abivax 91.96 Bn 91.96 Bn - 26.47 Mn
10 Vericel 2.04 Bn 1.90 Bn 49.27 Mn 11.29 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 11.29 Mn
Mar 31, 2026 11.29 Mn
Dec 31, 2025 8.42 Mn
Dec 31, 2025 8.42 Mn
Sep 30, 2025 8.70 Mn
Sep 30, 2025 8.70 Mn
Jun 30, 2025 10.14 Mn
Jun 30, 2025 10.14 Mn
Mar 31, 2025 11.51 Mn
Mar 31, 2025 11.51 Mn
Dec 31, 2024 7.92 Mn
Dec 31, 2024 7.92 Mn
Sep 30, 2024 9.22 Mn
Sep 30, 2024 9.22 Mn
Jun 30, 2024 9.52 Mn
Jun 30, 2024 9.52 Mn
Mar 31, 2024 9.83 Mn
Mar 31, 2024 9.83 Mn
Dec 31, 2023 6.91 Mn
Dec 31, 2023 6.91 Mn